Product Name: Human CB1 Antibody (GFB-024, Research Use)
Catalog Number: NBR-0312
Target Name: CB1
Trade Name: GFB-024
Antibody Drug Description: GFB-024 is intended for use in patients with kidney disease such as diabetic nephropathy. This study is the first time GFB-024 has been used in humans. GFB-024 is currently in a Phase 1 trial. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CB1
Synonyms: CANN6; CB-R; CB1; CB1A; CB1K5; CNR
Target Description: G-protein coupled receptor for endogenous cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2-arachidonoylglycerol (2-AG), as well as phytocannabinoids, such as delta(9)-tetrahydrocannabinol (THC) .
Ensembl: ENSG00000118432
Uniprot: P21554